U.S. Biotech Stock News

NYSE:LOMA
NYSE:LOMABasic Materials

Does Weaker 2025 Results And ESG Progress Change The Bull Case For Loma Negra (LOMA)?

Loma Negra Compañía Industrial Argentina Sociedad Anónima has released its fourth quarter and full-year 2025 results, reporting AR$225,233 million in Q4 sales and AR$6,245 million in net income, with full-year sales of AR$848,087 million and net income of AR$23,585 million, all lower than the prior year. Amid softer cement volumes, pressure on margins, and a steep drop in earnings per share, Loma Negra still pointed to a stronger concrete segment and ESG progress, including reduced CO₂...
NYSE:RDN
NYSE:RDNDiversified Financial

Assessing Radian Group’s Valuation After Its Latest Earnings Beat And Mortgage Credit Risk Role

Why Radian Group’s latest earnings beat matters Radian Group (RDN) recently beat earnings expectations, drawing fresh attention to its role in mortgage credit risk management and the broader housing finance system, including its real estate transaction support services. See our latest analysis for Radian Group. Radian Group’s share price, which last closed at $32.99, has seen pressure recently with a 90 day share price return of 8.84% and a year to date share price return of 8.16%, even as...
NYSE:COF
NYSE:COFConsumer Finance

Is Capital One’s 360 Savings Settlement Reshaping the Investment Case For Capital One Financial (COF)?

In early March 2026, Capital One Financial agreed to a proposed class action settlement over its 360 Savings accounts, including a US$425.00 million Settlement Fund and a commitment to align future 360 Savings interest rates with its 360 Performance Savings product, subject to court approval. The case highlights how differences in interest paid on similar-looking products and alleged disclosure gaps can create substantial legal, financial, and reputational repercussions for a large consumer...
NYSE:XPEV
NYSE:XPEVAuto

Is XPeng (XPEV) Quietly Pivoting From EV Maker to Full-Stack Physical AI Platform?

In February 2026, XPeng reported deliveries of 15,256 vehicles and rolled out nationwide test drives of its new VLA 2.0 autonomous driving system across 732 stores in China, while also starting construction plans for a Guangzhou factory to mass-produce its IRON humanoid robot by year-end. Together with exploratory cooperation talks involving Stellantis and continued focus on advanced driver-assistance technology, these moves highlight XPeng’s ambition to position itself as both an...
NasdaqGS:XP
NasdaqGS:XPCapital Markets

XP (NasdaqGS:XP) Valuation Check After Brazil Prediction Market And Stablecoin Launches

XP (XP) is in focus after two product launches in Brazil: a partnership with prediction market platform Kalshi and the rollout of USDXP, a US$ backed stablecoin issued via Clear Corretora. See our latest analysis for XP. XP's recent product launches come after a mixed period for the share price. A 30 day share price return of an 8.4% decline contrasts with a 12.5% share price gain year to date and a 25.3% 1 year total shareholder return, suggesting momentum has softened in the short term...
NasdaqGS:SHC
NasdaqGS:SHCLife Sciences

Why Sotera Health (SHC) Is Down 8.5% After a $382 Million Share Sale And What's Next

Sotera Health recently completed a follow-on equity offering of US$381.75 million, issuing 25,000,000 common shares at US$15.27 each, boosting its capital base but increasing its share count. This fresh equity capital gives Sotera Health more financial flexibility to fund growth projects or reduce debt, while shareholders weigh the impact of dilution. Next, we'll examine how this sizeable equity raise and resulting dilution could reshape Sotera Health's investment narrative going...
NYSE:MET
NYSE:METInsurance

Assessing MetLife (MET) Valuation After Recent Share Price Weakness

Recent performance snapshot MetLife (MET) has drawn attention after a recent stretch of weaker share performance, with the stock showing negative returns over the past week, month, past 3 months, year to date, and past year. At a last close of $67.97 and annual revenue of about $77.1b against net income of roughly $3.2b, investors are weighing how this large US insurer’s fundamentals line up with the recent pullback. See our latest analysis for MetLife. MetLife’s recent 1 day share price...
NYSE:MRSH
NYSE:MRSHInsurance

Is Marsh & McLennan (MRSH) Blurring The Line Between Consulting And Risk To Sharpen Its Edge?

In March 2026, Marsh announced that Nick Studer will become President and CEO of Marsh Risk on April 1, 2026, succeeding Martin South, who moves into an enterprise-wide role as Chief Client Officer while both remain on the Executive Committee reporting to John Doyle. This leadership reshuffle strengthens Marsh’s focus on client impact and innovation, bringing Oliver Wyman’s consulting expertise closer to the core risk business while a new Oliver Wyman CEO is named. Next, we’ll examine how...
NasdaqGS:MAT
NasdaqGS:MATLeisure

Does Barbie x CCM Shift Mattel’s (MAT) Brand From Toys To Broader Lifestyle Platform?

In recent weeks, CCM Hockey and Mattel announced the launch of an all-new Barbie x CCM Collection of performance hockey gear and apparel aimed at making the sport more inclusive and expressive for a new generation of girls and athletes. This collaboration highlights Mattel’s broader push to extend the Barbie brand beyond traditional toys into sports and lifestyle, aligning with its ambition to build a wider entertainment and consumer-products platform. We’ll now look at how this inclusive...
NasdaqGS:NFLX
NasdaqGS:NFLXEntertainment

Netflix Reorganization Puts Marketing Efficiency And Valuation In Investor Focus

Netflix, ticker NasdaqGS:NFLX, is cutting several dozen roles across its global product and creative studio teams. The move is part of a wider internal reorganization focused on marketing assets and live experience content. The restructuring affects how Netflix coordinates global marketing campaigns and manages cross team workflows. For you as an investor, this relates to how NasdaqGS:NFLX runs its core subscription and content business, not a single show or feature. The product and...
NYSE:BAC
NYSE:BACBanks

Buffett Exit Cuts Bank Of America Stake As Valuation Debate Grows

Warren Buffett’s Berkshire Hathaway has cut its stake in Bank of America (NYSE:BAC) by around 50% ahead of his retirement. The move reduces the influence of a long-standing, high profile shareholder that first invested in the bank in 2011. The reduction in holdings has been paired with a pivot toward other sectors in Berkshire’s portfolio. Bank of America is one of the largest US based banks, with a focus on consumer banking, wealth management, and corporate and investment services. The...
NasdaqGS:ORIC
NasdaqGS:ORICBiotechs

A Look At ORIC Pharmaceuticals (ORIC) Valuation After Competitor Tazverik Withdrawal And Analyst Support

ORIC Pharmaceuticals (ORIC) came under pressure after Ipsen pulled cancer drug Tazverik over concerns about secondary hematologic malignancies, even though ORIC said its prostate cancer candidate rinzimetostat showed no malignancies in preclinical toxicity testing. See our latest analysis for ORIC Pharmaceuticals. At a share price of US$11.90, ORIC has seen a 19.12% 30 day share price return and 45.65% year to date. The 1 year total shareholder return of 52.76% and 3 year total shareholder...
NYSE:BA
NYSE:BAAerospace & Defense

Assessing Boeing (BA) Valuation After Fresh 737 MAX Wiring Quality Concerns

Boeing (BA) is back in the spotlight after disclosing minor electrical wiring damage on undelivered 737 MAX jets, a quality issue that has weighed on the share price despite steady full year delivery guidance. See our latest analysis for Boeing. Those wiring disclosures have fed into recent share price weakness, with Boeing’s 7 day share price return of 9.18% and 30 day return of 13.61% standing in contrast to a 1 year total shareholder return of 29.71%. This suggests momentum has cooled in...
NasdaqGS:SFNC
NasdaqGS:SFNCBanks

Simmons First Earnings Beat Sparks Questions On Value And Dividend Support

Simmons First National (NasdaqGS:SFNC) reported quarterly results that exceeded revenue and EPS expectations. The bank highlighted resilient operations and solid performance within its regional banking footprint. The update adds fresh information on the company’s current business momentum that has not been reflected in recent coverage. Simmons First National, trading at $18.61, has delivered a quarter that came in ahead of both revenue and earnings forecasts, which puts a fresh spotlight on...
NasdaqGS:ROST
NasdaqGS:ROSTSpecialty Retail

Assessing Ross Stores (ROST) Valuation After Strong Multi Year Shareholder Returns

Recent share performance context Ross Stores (ROST) has drawn investor attention after its shares delivered a 68.3% total return over the past year, along with a 12.9% gain year to date and a 12% return in the past 3 months. See our latest analysis for Ross Stores. At a share price of US$206.28, Ross Stores has recently eased back over the past week even after a solid 30 day share price return, while its 1 year total shareholder return of 68.3% and 3 year total shareholder return of 108.6%...
NYSE:MOS
NYSE:MOSChemicals

Mosaic (MOS) Is Up 11.4% After Rare Earths Pivot And Dividend Update - Has The Bull Case Changed?

The Mosaic Company recently announced a quarterly dividend of US$0.2200 per share payable on June 2, 2026, while also advancing plans with Rainbow Rare Earths Ltd. to develop the Uberaba rare earths project in Brazil through new processing facilities targeting production by 2030. This move signals Mosaic’s effort to extract more value from its existing phosphate operations by recovering rare earth elements, potentially diversifying revenue beyond traditional fertilizers. Next, we’ll examine...
NasdaqGS:WOOF
NasdaqGS:WOOFSpecialty Retail

Is It Time To Reconsider Petco Health and Wellness Company (WOOF) After The Recent Share Price Surge

This article examines whether Petco Health and Wellness Company, at around US$3.62, may represent a bargain or a value trap by exploring what the current share price might indicate about the business. The stock has recently experienced sharp moves, with returns of 52.1% over the last 7 days, 44.2% over the last 30 days, 27.0% year to date and 51.5% over the last year. However, the 3 year and 5 year returns show declines of 63.1% and 84.4%, which tells a very different story. These swings...
NasdaqCM:CORT
NasdaqCM:CORTPharmaceuticals

Corcept Therapeutics (CORT) Is Down 5.1% After FDA Relacorilant Rejection And Investor Lawsuits - What's Changed

In late 2025, Corcept Therapeutics received a Complete Response Letter from the FDA rejecting its New Drug Application for relacorilant on the grounds of insufficient evidence of effectiveness, prompting multiple securities class action lawsuits alleging the company misrepresented the drug’s regulatory prospects and prior FDA feedback. These lawsuits focus not just on the setback for relacorilant, but on claims that Corcept withheld repeated FDA concerns while continuing to promote the drug...
NYSE:ORI
NYSE:ORIInsurance

Old Republic Leadership Shift And Valuation Gap As Wordekemper Takes Helm

Old Republic International (NYSE:ORI) has appointed Doug Wordekemper as CEO of Old Republic Professional. The move is part of a broader organizational leadership change within the Professional division. The appointment brings a leader with extensive industry experience into a key role overseeing the Professional business. Old Republic International, through its Professional division, focuses on specialty insurance solutions for professional liability and related risks. Leadership changes in...
NasdaqCM:KARO
NasdaqCM:KAROSoftware

Karooooo (NasdaqCM:KARO) Valuation Check As Cartrack Crosses Two Million Subscriber Milestone

Subscriber milestone puts Karooooo (KARO) in focus Cartrack, a subsidiary of Karooooo (KARO), has surpassed two million active subscribers in South Africa. This milestone puts the group’s mobility SaaS model and customer-focused execution firmly on investors’ radar. See our latest analysis for Karooooo. Karooooo’s latest subscriber milestone lands after a period where the share price has moved steadily rather than sharply, with a 5.69% year to date share price return and a 19.93% one year...
NYSE:WEX
NYSE:WEXDiversified Financial

Is WEX (WEX) Offering Value After Recent Share Price Volatility And Mixed Valuation Signals

If you are wondering whether WEX at around US$159.95 is priced fairly or offering value, you are not alone. This article is built to help you assess that question using several valuation tools. The stock has been relatively mixed recently, with a 7.8% return year to date and 3.8% over the last year, alongside a 4.3% decline over the past week and a 1.4% gain over the last 30 days. These movements can change how the market is thinking about its risk and opportunity. Recent coverage has...
NYSE:F
NYSE:FAuto

NTSB BlueCruise Hearing Puts Ford Safety And ADAS Ambitions Under Review

The National Transportation Safety Board plans to hold a hearing on Ford Motor's BlueCruise hands free driving system following two fatal crashes. The hearing will examine how the advanced driver assistance system was used in the incidents and whether additional safety measures are needed. The review puts Ford's automated driving technology and safety practices under closer regulatory and public scrutiny. For investors watching NYSE:F at a current share price of $11.67, this hearing comes...
NasdaqGS:LKQ
NasdaqGS:LKQRetail Distributors

Assessing LKQ (LKQ) Valuation After A Sharp Share Price And One Year Total Return Decline

LKQ stock performance context LKQ (LKQ) shares closed at $29.34, with the stock showing a 1 day return of 1.38% and a 7 day decline of 6.77%. This sets the stage for a closer look at its recent performance. See our latest analysis for LKQ. At the current share price of $29.34, LKQ’s 30 day share price return of a 13.96% decline sits alongside a 1 year total shareholder return of a 26.95% decline, pointing to fading momentum rather than a short term blip. If LKQ’s recent pullback has you...
NYSE:T
NYSE:TTelecom

Should AT&T’s US$250 Billion AI-Era Network Build-Out Plan Require Action From AT&T (T) Investors?

Earlier this month, AT&T announced over US$250.00 billion of planned U.S. connectivity investment through 2030, launched more flexible Unlimited Your Way wireless plans, and issued long-dated Canadian dollar bonds to support its network build-out. Together, these moves highlight AT&T’s push to reposition itself as a core connectivity platform for AI-era data demand while sharpening its consumer value proposition. Now we’ll examine how AT&T’s US$250.00 billion connectivity build-out plan...